![](/images/graphics-bg.png)
Once-Daily Tacrolimus Extended-Release Formulation : 1 Year after Conversion in Stable Pediatric Kidney Transplant Recipients
المؤلفون المشاركون
Ahlenstiel, Thurid
Pape, Lars
Heidotting, Nele
المصدر
International Journal of Nephrology
العدد
المجلد 2011، العدد 2011 (31 ديسمبر/كانون الأول 2011)، ص ص. 1-4، 4ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2011-05-22
دولة النشر
مصر
عدد الصفحات
4
التخصصات الرئيسية
الملخص EN
It is speculated that a once-daily dosage of immunosuppression can increase adherence and thereby graft survival.
Until now, there have been no studies on once-daily use of Tacrolimus extended-release formulation (TAC-ER) in children following pediatric kidney transplantation.
In 11 stable pediatric kidney recipients >10 years, efficacy, safety, and tolerability of a switch to TAC-ER were observed over one year.
Adherence was determined by use of the BAASIS-Scale Interview and comparison of individual variability of Tacrolimus trough levels.
Over the observation period, two acute rejections were observed in one girl with nonadherence and repeated Tacrolimus trough levels of 0 ng/m.
Beside this, there were no acute rejections in this trial.
TAC dose was increased in 3/11 patients and decreased in 2/11 patients within the course of the study.
Six patients did not require a dose adjustment.
All but one patient had a maximum of 1 dose change during therapy.
Mean Tacrolimus dose, trough levels, and Glomerular filtration rates were also stable.
Adherence, as measured by BAASIS-Scale Interview and coefficient of variation of Tacrolimus trough levels, was good at all times.
It is concluded that conversion to Tac-ER is safe in low-risk children following pediatric kidney transplantation.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Pape, Lars& Heidotting, Nele& Ahlenstiel, Thurid. 2011. Once-Daily Tacrolimus Extended-Release Formulation : 1 Year after Conversion in Stable Pediatric Kidney Transplant Recipients. International Journal of Nephrology،Vol. 2011, no. 2011, pp.1-4.
https://search.emarefa.net/detail/BIM-447687
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Pape, Lars…[et al.]. Once-Daily Tacrolimus Extended-Release Formulation : 1 Year after Conversion in Stable Pediatric Kidney Transplant Recipients. International Journal of Nephrology No. 2011 (2011), pp.1-4.
https://search.emarefa.net/detail/BIM-447687
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Pape, Lars& Heidotting, Nele& Ahlenstiel, Thurid. Once-Daily Tacrolimus Extended-Release Formulation : 1 Year after Conversion in Stable Pediatric Kidney Transplant Recipients. International Journal of Nephrology. 2011. Vol. 2011, no. 2011, pp.1-4.
https://search.emarefa.net/detail/BIM-447687
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-447687
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)